NCT01712490 2026-02-27A Frontline Therapy Trial in Participants With Advanced Classical Hodgkin LymphomaTakedaPhase 3 Completed1,334 enrolled 23 charts
NCT06960577 2026-02-23Perioperative Durvalumab With Neoadjuvant ddMVAC or Gemcitabine/Cisplatin in Patients With Muscle-invasive Bladder Cancer (NIAGARA-2)AstraZenecaPhase 3 Recruiting150 enrolled